Avandia one vote away from elimination

Sen. Charles Grassley, the ranking Republican on the Senate Finance Committee, says that the FDA’s Drug Safety Oversight Board voted 8-7 on Oct. 2 to keep the scandal-plagued diabetes drug Avandia on the market. The result was kept from the public.

Wow, what a nailbiter. That’s enough to give Glaxo execs a heart attack (or at least increase the risk of one by, oh, 43 percent.)

(Via Reuters.)

193

Related Posts

Comments (1)

Grassley appears to be one of our greater allies. Did you know he provides his own personal fax line on his website for potential whistleblowers?

Leave a comment